132 related articles for article (PubMed ID: 16012325)
21. [Infection control in neutropenia induced by high-dose cytarabine chemotherapy].
Miyazaki M; Senzaki K; Kiyoi H; Kohno S; Noda Y; Nabeshima T
Gan To Kagaku Ryoho; 2004 Nov; 31(12):2011-5. PubMed ID: 15570930
[TBL] [Abstract][Full Text] [Related]
22. "Reaction to cytarabine (Ara-C) treatment in patients with concurrent Staphylococcus aureus infection: a coalition between Ara-C and superantigens?".
Savaşan S; Warrier I; Can E; Can M; Gedikoğlu G
Med Pediatr Oncol; 1998 Apr; 30(4):263-4. PubMed ID: 9473764
[No Abstract] [Full Text] [Related]
23. Marked telomere shortening in mobilized peripheral blood progenitor cells (PBPC) following two tightly spaced high-dose chemotherapy courses with G-CSF.
Ricca I; Compagno M; Ladetto M; Rocci A; Dell'Aquila M; Omedè P; De Marco F; D'Antico S; Caracciolo D; Ferrero D; Carlo-Stella C; Tarella C
Leukemia; 2005 Apr; 19(4):644-51. PubMed ID: 15716989
[TBL] [Abstract][Full Text] [Related]
24. Comparison of two schedules of intermediate-dose methotrexate and cytarabine consolidation therapy for childhood B-precursor cell acute lymphoblastic leukemia: a Pediatric Oncology Group study.
Land VJ; Shuster JJ; Crist WM; Ravindranath Y; Harris MB; Krance RA; Pinkel D; Pullen DJ
J Clin Oncol; 1994 Sep; 12(9):1939-45. PubMed ID: 8083715
[TBL] [Abstract][Full Text] [Related]
25. Viridans streptococci bacteraemia in children with fever and neutropenia: a case-control study of predisposing factors.
Paganini H; Staffolani V; Zubizarreta P; Casimir L; Lopardo H; Luppino V
Eur J Cancer; 2003 Jun; 39(9):1284-9. PubMed ID: 12763218
[TBL] [Abstract][Full Text] [Related]
26. Use of recombinant human granulocyte colony-stimulating factor to increase chemotherapy dose-intensity: a randomized trial in very high-risk childhood acute lymphoblastic leukemia.
Michel G; Landman-Parker J; Auclerc MF; Mathey C; Leblanc T; Legall E; Bordigoni P; Lamagnere JP; Demeocq F; Perel Y; Auvrignon A; Berthou C; Bauduer F; Pautard B; Schneider P; Schaison G; Leverger G; Baruchel A
J Clin Oncol; 2000 Apr; 18(7):1517-24. PubMed ID: 10735900
[TBL] [Abstract][Full Text] [Related]
27. Systemic high-dose ara-C for the treatment of meningeal leukemia in adult acute lymphoblastic leukemia and non-Hodgkin's lymphoma.
Morra E; Lazzarino M; Inverardi D; Brusamolino E; Orlandi E; Canevari A; Pagnucco G; Bernasconi C
J Clin Oncol; 1986 Aug; 4(8):1207-11. PubMed ID: 3461134
[TBL] [Abstract][Full Text] [Related]
28. [Effect of modified FLAG regimen therapy on 33 patients with relapsed/refractory leukemia].
Meng FY; Yang LJ; Xu B; Liu XL; Zheng WY; Zhang Y; Huang F; Sun J; Liu QF
Ai Zheng; 2003 Dec; 22(12):1330-3. PubMed ID: 14693062
[TBL] [Abstract][Full Text] [Related]
29. Procalcitonin as a Marker of Bacteremia in Patients With Fever and Acute Lymphoblastic Leukemia.
Vyles D; Gnagi F; Bulloch B; Muenzer J; Hu C
Pediatr Emerg Care; 2016 Sep; 32(9):590-3. PubMed ID: 26785096
[TBL] [Abstract][Full Text] [Related]
30. Toxicity and efficacy of intrathecal liposomal cytarabine in children with leukemia/lymphoma relapsing in the central nervous system: a retrospective multicenter study.
Parasole R; Petruzziello F; Messina C; Barisone E; Pession A; Locatelli F; Micalizzi C; Cesaro S; Testi AM; De Matteo A; Varotto S; Berger M; Morello W; Menna G; Poggi V
Leuk Lymphoma; 2015 Mar; 56(3):650-5. PubMed ID: 24882262
[TBL] [Abstract][Full Text] [Related]
31. The role of systemic high-dose cytarabine in the treatment of central nervous system leukemia. Clinical results in 46 patients.
Morra E; Lazzarino M; Brusamolino E; Pagnucco G; Castagnola C; Bernasconi P; Orlandi E; Corso A; Santagostino A; Bernasconi C
Cancer; 1993 Jul; 72(2):439-45. PubMed ID: 8319175
[TBL] [Abstract][Full Text] [Related]
32. Intraventricular concentration times time (C x T) methotrexate and cytarabine for patients with recurrent meningeal leukemia and lymphoma.
Moser AM; Adamson PC; Gillespie AJ; Poplack DG; Balis FM
Cancer; 1999 Jan; 85(2):511-6. PubMed ID: 10023723
[TBL] [Abstract][Full Text] [Related]
33. [Skin toxicity associated with bolus infusion of low-dose cytarabine].
Takeuchi M; Tanizawa A; Fukumoto Y; Kikawa Y; Mayumi M
Rinsho Ketsueki; 2001 Mar; 42(3):216-7. PubMed ID: 11345785
[TBL] [Abstract][Full Text] [Related]
34. Mitoxantrone and high-dose cytarabine as salvage therapy for refractory non-Hodgkin's lymphoma.
Ho AD; del Valle F; Rückle H; Schwammborn J; Schlimok G; Hiddemann W; Meusers P; Thiel E; Dörken B; Hunstein W
Cancer; 1989 Oct; 64(7):1388-92. PubMed ID: 2776103
[TBL] [Abstract][Full Text] [Related]
35. [The use of hematopoietic growth factors G-CSF/GM-CSF in the treatment of neutropenia in children with acute lymphoblastic leukemia and non-Hodgkin's lymphomas].
Nowak K; Pekacka K; Trelińska J; Stolarska M; Bodalski J
Wiad Lek; 1998; 51 Suppl 4():237-42. PubMed ID: 10731975
[TBL] [Abstract][Full Text] [Related]
36. The cytosine arabinoside (Ara-C) syndrome.
Castleberry RP; Crist WM; Holbrook T; Malluh A; Gaddy D
Med Pediatr Oncol; 1981; 9(3):257-64. PubMed ID: 6941069
[TBL] [Abstract][Full Text] [Related]
37. Intensive timed sequential remission induction chemotherapy with high-dose cytarabine for childhood acute myeloid leukemia.
Loeb DM; Bowers DC; Civin CI; Friedman AD
Med Pediatr Oncol; 2001 Oct; 37(4):365-71. PubMed ID: 11568900
[TBL] [Abstract][Full Text] [Related]
38. Granulocyte-macrophage colony-stimulating factor support in therapy of high-risk acute lymphoblastic leukemia in children.
Saarinen-Pihkala UM; Lanning M; Perkkiö M; Mäkipernaa A; Salmi TT; Hovi L; Vettenranta K
Med Pediatr Oncol; 2000 May; 34(5):319-27. PubMed ID: 10797353
[TBL] [Abstract][Full Text] [Related]
39. Risk of repeated febrile episodes during chemotherapy-induced granulocytopenia in children with cancer: a prospective single center study.
Bagnasco F; Haupt R; Fontana V; Valsecchi MG; Rebora P; Caviglia I; Caruso S; Castagnola E
J Chemother; 2012 Jun; 24(3):155-60. PubMed ID: 22759760
[TBL] [Abstract][Full Text] [Related]
40. Procalcitonin in pediatric emergency departments for the early diagnosis of invasive bacterial infections in febrile infants: results of a multicenter study and utility of a rapid qualitative test for this marker.
Fernández Lopez A; Luaces Cubells C; García García JJ; Fernández Pou J;
Pediatr Infect Dis J; 2003 Oct; 22(10):895-903. PubMed ID: 14551491
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
